Phase II study of pembrolizumab plus olaparib in the treatment of patients with advanced cholangiocarcinoma von He, Aiwu Ruth, Weinberg, Benjamin Adam, Noel, Marcus Smith, Milic, Violeta P, Prins, Petra, Wang, Hongkun, Hartley, Marion L., Marshall, John

Volltext